|
GSK announces new commitments to fight HIV/AIDS in Sub-Saharan Africa
|
15 July 2009 |
|
GSK further extends its product portfolio in the Middle East and North Africa
|
06 July 2009 |
|
GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs
|
25 June 2009 |
|
GSK announces a strategic alliance with Dr. Reddy's Laboratories Ltd
|
18 June 2009 |
|
GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China
|
11 June 2009 |
|
World Health Organization grants Global Prequalification to GSK's Rotarix⢠vaccine
|
08 June 2009 |
|
US Department of Health and Human Services (HHS) purchases GSK's A (H1N1) influenza antigen
|
27 May 2009 |
|
GlaxoSmithKline update: A (H1N1) influenza vaccine development
|
19 May 2009 |
|
GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million
|
08 May 2009 |
|
GlaxoSmithKline update: influenza A (H1N1)
|
06 May 2009 |
|
OTC weight loss aid is available in pharmacies across Europe
|
21 April 2009 |
|
GSK submits Tyverb®/Tykerb® for first-line treatment of metastatic breast cancer in Europe, US
|
02 April 2009 |
|
GSK initiates phase III programme for novel type 2 diabetes medication, Syncria® (albiglutide)
|
20 February 2009 |
|
GlaxoSmithKline and Idenix Pharmaceuticals sign worldwide license agreement for IDX899
|
10 February 2009 |
|
GSK to drive growth in emerging markets with acquisition of UCB products
|
27 January 2009 |
|
GlaxoSmithKline successfully completes tender offer for shares of Genelabs Technologies, Inc.
|
08 January 2009 |
|
GlaxoSmithKline to cease providing corporate political contributions
|
23 December 2008 |
|
GSK analysis shows Seretide/Advair is a well tolerated and effective medicine
|
08 December 2008 |
|
GSK and Neptunus form joint venture for the co-development of flu vaccines
|
24 November 2008 |
|
GlaxoSmithKline to acquire Genelabs Technologies to increase focus on novel small molecule therapies
|
01 November 2008 |